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Abstract Nonsurgical embryo transfer (NSET) of
blastocysts to pseudopregnant female recipients pro-
vides many benefits over surgical implantation with less
distress for the mice, no anesthesia or analgesia
required and a considerable reduction in implantation
time per mouse. Although a disposable device to
perform NSET is on the market since 2009, it is not
generally used in transgenic facilities, most likely
because surgical implantation is efficient and inexpen-
sive. Here, we report that with several refinements to
the original protocol, the NSET method becomes very
attractive and outperforms the traditional surgical
transfer on basis of pregnancy rate, birth rate and
implantation-related discomfort. Furthermore, repeated
use of the same NSET device on several recipient
females reduces the costs to a reasonable level. The data
presented covers all embryo transfers over the last
5 years at the transgenic facility of the Netherlands
Cancer Institute, of which the last 2 years were
performed exclusively with NSET.
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Generating genetically engineered mice requires a
diversity of skills and a considerable investment in
time. Typically, embryonic stem cells (ESCs) are
modified in vitro to introduce specific genetic altera-
tions, after which the ESCs are injected into blastocysts.
Next, the ESC-injected blastocysts are transferred in
pseudopregnant female recipients in order to obtain
chimeric mice with contribution of the modified ESCs
to all tissues in order to achieve transmission of the
genetic modifications to the next generation. All steps
are crucial and need to be optimized. Recently, we have
reported our efforts to optimize both the ESC culture
conditions and the ESC microinjection method (Huij-
bers et al. 2014). Here, we focus on the transfer of ESC-
injected embryos in female recipients. Currently, the
golden standard to perform embryo transfer is surgical
implantation. However, this is an invasive procedure
and requires incisions through skin and muscle and
penetration of the peritoneal cavity and reproductive
tract. Furthermore, it requires externalization of internal
organs and wound closure. The procedure is time
consuming, requires significant technical expertise and
necessitates anesthesia and analgesia in order minimize
the discomfort of the foster mothers. In 2009, a less
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invasive nonsurgical embryo transfer (NSET) method
was presented as an alternative and commercialized by
ParaTechs (Lexington, KY, USA) (Green et al. 2009;
Steele et al. 2013). This NSET method is based on the
introduction of a disposable tapered Teflon catheter in
vagina of the recipient female mouse, to expel manip-
ulated embryos directly through the cervix into either
one of the uterine horns of the mouse. The speed and
simplicity of this process combined with the reduced
burden/discomfort on the recipient mice made us adopt
the NSET procedure for transfer of all our ESC-injected
blastocysts from the beginning of 2012 onwards. In this
report, we present our experiences and results during
our transition from the surgical to the NSET procedure.
In 2011, we explored the NSET method as a
possible replacement for the surgical embryo transfers
by following the protocol provided with the NSET
device. As shown in Table 1, we obtained similar
pregnancy rates as compared to the surgical transfers
performed in earlier years, however the percentage of
live born mice was disappointing. By introducing
further refinements, we achieved marked improve-
ments, which were evident in the following years. The
results even surpassed the efficiency of the surgical
procedure on all fronts when comparing the combined
figures of 2009–2010, i.e. surgical implantation only,
versus the combined figures of 2012–2013, i.e.
exclusively performed with the adapted NSET method
(Table 1). Pregnancy rates increased from 76 to 85 %.
Percentage of live born mice improved dramatically
from 21 to 35 %. Furthermore, a complete absence of
severe complications related to embryo transfer using
the NSET method as opposed to 4 % with surgical
implantation. The adapted NSET protocol is illus-
trated and explained in Fig. 1. Also a demonstration
video is provided (Supplement video 1). The refine-
ments that contributed to these encouraging results are
explained in more detail below.
(I) Avoid contamination with mineral oil. After
microinjection, we pool the embryos in a drop of
KSOM. This drop is covered with mineral oil to
prevent evaporation. Before the transfer, the embryos
are washed and transferred to separate drops of
KSOM, with 15 blastocysts per drop (Fig. 1a). Occa-
sionally, remnants of mineral oil are still present in
these drops and can cause problems with the embryo
transfer as mineral oil acts as a lubricant to the NSET
catheter tip and can clog the catheter tip to prevent
correct placement of embryos in the uterine horn. A
complication also mentioned at the ParaTechs web-
site. We simply avoid contact of the NSET catheter
with the oil droplets when aspirating the injected
blastocysts. Furthermore, we carefully rinse the cath-
eter tip in clean drops of KSOM between transfers
(Fig. 1a, bottom row) and check under the microscope
whether the tip is sufficiently clean.
(II) Transfer 15 injected blastocysts per recipient
female mouse. The protocol provided with the NSET
Table 1 Comparison between pregnancy rate, birth rate and implantation-related fatalities between surgical implantation and NSET
Surgical NSET
2009 2010 2011a 2012 2013
Pregnancy rate
No. of implantations 52 66 143 190 146
No. of fosters used 159 196 432 584 328
No. of fosters pregnant 115 155 306 492 285
% Pregnancy 72.3 79.0 70.8 84.2 86.9
Birth rate
No. of blastocysts transferred 1,787 2,232 6,698 8,783 5,615
No. of live-borns 350 485 669 3,125 1,845
% Live born pups 19.6 21.7 10.0 35.6 32.9
Implantation-related fatality
No. of fosters died after transfer 6 7 0 0 0
% Fatality 3.8 3.6 0 0 0
a Start-up period in which several refinements were made to the original protocol
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device indicates a range of 12–20 embryos per
recipient. Typically, we implant 15 embryos. We have
transferred higher numbers, but then encountered
more non-pregnant mice as well as fosters having
difficulties giving natural birth. In cases where the
mice did not deliver on due date, a caesarian section
Fig. 1 a Configuration of KSOM (Cat. No. MR-106-D;
Millipore) drops on the cover of a 35 mm petridish (Falcon).
The two drops in top row are used for consecutive washing steps
of the ESC-injected embryos. Drops of second row contain the
embryos to be transferred in a female recipient: each drop
contains 15 blastocysts. The two drops in bottom row are used to
rinse the NSET device after transfers. Volume of top and bottom
drops is 100 ll and the middle drops 50 ll. Transfer of embryos
between drops is performed by mouth pipette. b Materials
required to perform NSET: a Gilson P2 pipette, the NSET
device, a small and big speculum. Note, we omit the big
speculum in our NSET protocol and exclusively use the small
one. c Aspiration of embryos. Under a stereomicroscope the
injected blastocysts are carefully aspirated with a catheter tip
attached to a P2 pipette, dialed to 1.8 ll, until the first plunger
stop. Next the pipette was dialed to 2.0 ll to create a small air
bubble at the beginning of the tip. d Preparation of recipient
mouse for effective transfer. Pick up the unanaesthetized
pseudopregnant female mouse by the tail with forefinger and
thumb and let her grab the metal grid with her forelimbs. Fix the
body by placing the two free fingers at the bass of the tail.
Carefully insert the small speculum into the vagina. e Position-
ing of the female for effective transfer. Lift the rear body of the
mouse at an angle of 45–70 in order to provide the most
optimal entrance of the catheter tip in the cervix and uterine
horn. f Introduction of NSET device. Pick up the NSET device
loaded with 15 blastocysts and insert the tip in the speculum
until it touches the edge of the speculum. g Embryo transfer. The
blastocysts are released by pushing the plunger all the way till
the second click. Without releasing the plunger, the NSET
device is pulled out from the speculum. The speculum is
removed and the mouse placed in a clean cage. h A typical litter
obtained with NSET
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was performed a day later. Here, we often observed
few, but large pups and embryo resorption in the
uterus.
(III) Use the B6CBAF1/OlaHsd (Harlan) strain for
the pseudopregnant recipients. Initially, we used the
CD-1 strain (Charles River) as a recipient as suggested
by ParaTechs, however we had difficulties to achieve
successful entry into the uterine horn. We therefore,
returned to using the strain we routinely used for our
embryo transfer, i.e. the B6CBAF1/OlaHsd. The
females on this background produce decent numbers
of offspring and are caring mothers. Furthermore, the
B6CBAF1/OlaHsd mice are generally leaner and
calmer as opposed to CD-1. We start using the
recipients when they reach 8 weeks of age and weigh
between 20 and 35 g. Once the mice weight passes
35 g we no longer use them regardless of age.
(IV) Carefully select recipient female mice. One of
the downsides of the NSET approach is the inability to
evaluate whether a recipient female is stimulated or
primed for implantation by observing the ovaries and
uterus as can be done during surgical implantation.
Transfer of embryos in unstimulated females will
generally not yield successful pregnancies. We follow
a set of simple rules for selecting appropriate recipient
female mice suitable for the NSET method. First, only
recipient female mice in their pro-estrous or estrous
cycle are mated with vasectomised males as assessed
by appearance of the vagina (Champlin et al. 1973).
Second, we only implant in females with an evident
vaginal plug. Third, we perform embryo transfer 2–3 h
post blastocyst injection with ESCs. In brief, we select
the appropriate recipient females and place them with
vasectomised males at 3 p.m. The next day, we check
for plugs at 8 a.m., i.e. 0.5 days post coitus (dpc). Two
days later, ESC microinjection is performed in the
morning and NSET in the afternoon between 2 and 3
p.m. In case of shortage of 2.5 dpc recipients on the
day of embryo transfer, 3.5 dpc recipients can be used
for the transfer of blastocysts. However, in this case
NSET should be performed slightly earlier, between
12 a.m. and 1 p.m. In our hands, this works equally
well.
(V) Position recipient females at the correct angle
to allow undisturbed insertion of the NSET catheter
tip. Select a recipient mouse in a calm state and let her
grab the wire grid with the forelimbs and raise the back
to insert the small speculum (Fig. 1d). Upon insertion
of the NSET catheter tip, the body and speculum is
positioned at an angle of 45–70 (Fig. 1e). We find
that this angle provides the best chance for the tip to
glide through the cervix and into the uterine horn
without hitting the cervix junction. In most cases, the
insertion into the uterine horn will happen in one try,
however if an obstruction is encountered, pull back the
tip and try to reposition the tip and recipient before
inserting it again. If the second try fails, try to use
another recipient. Forcing your way through the cervix
while trying to enter the uterine horn will cause the tip
to bend and result in poor or no delivery of the
blastocysts into the uterine horn and may cause injury
to the mouse.
(VI) Only use the small speculum. The NSET
protocol suggests to use first a small speculum to open
the vagina followed by a larger speculum. We find that
only using the small speculum to insert the catheter tip
works equally well. Using sense of touch, the catheter tip
is inserted through the small speculum and once it
touches the edge of the speculum the tip has entered
either one of the uterine horns (Fig. 1g). It is advisable to
use a light source for guidance while inserting the device.
(VII) The same NSET device can be used for
multiple transfers in 1 day. One of drawbacks for the
NSET device is the cost involved. A box comes with
ten devices, with a list price of $200–250 depending
on the order size. ParaTechs strongly advices single
use, which makes $20–25 per transfer. We routinely
re-use our NSET devices for multiple transfers in
1 day. Some caution has to be taken. Avoid possible
cross-contamination; only re-use the NSET device
when the same type of ESC-injected blastocysts are to
be implanted in multiple recipients. Between transfers,
carefully clean the catheter tip by flushing with KSOM
medium (Fig. 1a). It is good practice to check the
condition of the catheter tip before and after each
transfer under a stereomicroscope. Bent, dirty or
blocked tips impair the efficiency of transfer and these
should not be used. Under these conditions, we
perform up to eight transfers with a single device,
thereby substantially reducing costs.
(VIII) Practice makes perfect. Although the NSET
method is straightforward and easy to learn, especially
in comparison to the surgical implantation technique,
still it requires experience to achieve the optimal
results. In our first year of using the NSET method we
observed reduced pregnancy rates and a strong drop in
the number of live-born pups compared to the surgical
transfer (Table 1). The refinements we subsequently
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introduced have undoubtedly contributed to the
improved performance, however the increased expe-
rience in routinely performing the NSET method has
also played a role. Currently, training of new person-
nel to perform the NSET method takes one or two
sessions under supervision of a trained biotechnician.
After that regular applying the technique is advisable
for optimal results.
In conclusion, a range of relatively minor adapta-
tions to the original NSET protocol improve the
overall success rate of embryo transfer, even surpass-
ing the generally used surgical embryo transfer. The
adapted protocol is as simple as the original protocol
and can easily be implemented in any transgenic
facility. Our production data represent transfer of all
our ESC-injected blastocysts over the last 5 years and
do not include specific experiments to test the
contribution of each individual adjustment to the
protocol. We are therefore unable to state which
adjustments provides most gain. In light of the 3R’s in
animal research, i.e. replacement, reduction and
refinement, the NSET method is a valuable ‘‘refine-
ment’’ step as it causes less discomfort to the mice
(Steele et al. 2013). It might also lead to a ‘‘reduction’’,
as improved embryo transfer reduces the number of
fosters needed to obtain the required number of live
born offspring, for instance when sanitizing or re-
deriving strains. Recently, we ventured into Crispr/
Cas9 injections in zygotes (Wang et al. 2013; Yang
et al. 2013) and used both surgical and nonsurgical
embryo transfer and found that the transfer of blasto-
cysts derived from Crispr/Cas9 injected zygotes
resulted in poor performance as compared to direct
surgical implantation of the injected zygotes. Possibly,
this is due to the delayed in vitro development of
Crispr/Cas9 injected zygotes, as we have frequently
observed. Therefore, implementation of the NSET
method in transgenic facilities can provide consider-
able benefits, but should be applied correctly and in the
appropriate setting.
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